Gabriella Fabbrocini

133PUBLICATIONS
88CO-AUTHORS
Toxicology (incl. clinical toxicology)PharmacogenomicsAllergyGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (133)

|May 27, 2023
The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs.

Elisa Camela, Luca Potestio, Gabriella Fabbrocini

|Mar 17, 2023
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study.

Giacomo Caldarola, A Chiricozzi, M Megna

|Mar 14, 2023
Dupilumab-associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study.

Maddalena Napolitano, Gabriella Fabbrocini, Cataldo Patruno

|Dec 17, 2022
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge.

Angelo Ruggiero, Elisa Camela, Luca Potestio

Pageof 23